AM-001 Study represents a pivotal milestone in Galmed's transition to Aramchol Meglumine, an improved formulation of its lead compound in advanced clinical development – Aramchol Meglumine ...

(RTTNews) - Galmed Pharmaceuticals (GLMD) announced positive preliminary results from Part 1 of the Ph1 Bioavailability AM-001 Study of Aramchol Meglumine. The company said initial findings ...

Preferred NSAIDs in cattle are ketoprofen, meloxicam, and flunixin meglumine. A standard approach as simple as giving an NSAID can significantly improve industry practice. Regardless, current levels ...

UMD Professor of Cell Biology and Molecular Genetics Najib El-Sayed, co-lead author of the study, noted that the standard drug used to treat the disease—meglumine antimoniate—typically fails ...

The team found that patients who failed to respond to meglumine antimoniate showed a distinctive pattern in their immune system, a sustained inflammatory state called a type I interferon response.